<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://globalsecuritiesnews.com/en/north-america/canada/article/sernova-and-seraxis-merge-to-form-betanova-biotherapeutics/</loc>
    <news:news>
      <news:publication>
        <news:name>Global Securities News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-08T00:00:00.000Z</news:publication_date>
      <news:title>Sernova and Seraxis Merge to Form BetaNova Biotherapeutics</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://globalsecuritiesnews.com/en/north-america/united-states/article/milestone-pharma-wins-first-overseas-approval-for-heart-drug/</loc>
    <news:news>
      <news:publication>
        <news:name>Global Securities News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-08T00:00:00.000Z</news:publication_date>
      <news:title>Milestone Pharma Wins First Overseas Approval for Heart Drug</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://globalsecuritiesnews.com/en/north-america/united-states/article/monte-rosa-receives-50m-milestone-for-phase-2-study/</loc>
    <news:news>
      <news:publication>
        <news:name>Global Securities News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-08T00:00:00.000Z</news:publication_date>
      <news:title>Monte Rosa Receives $50M Milestone for Phase 2 Study</news:title>
    </news:news>
  </url>
</urlset>
